The worldwide gradient of autoimmune conditions

Autoimmunity Reviews

Volumn 9, Issue 5, 2010, Pages

  Selmi, Carlo ^a,b  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Geographical gradient; Systemic disease; Tolerance breakdown

Indexed keywords

AUTOIMMUNE DISEASE; EDITORIAL; EFFECTOR CELL; ENVIRONMENTAL FACTOR; GEOGRAPHIC DISTRIBUTION; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; MEDICAL RESEARCH;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; PERIODICALS AS TOPIC; PUBLICATIONS;

EID: 77649233937     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.02.004     Document Type: Editorial

References (100)

1. Shoenfeld Y., Selmi C., Zimlichman E., and Gershwin M.E. The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 31 (2008) 325-330
2. Hudson M., Rojas-Villarraga A., Coral-Alvarado P., Lopez-Guzman S., Mantilla R.D., Chalem P., et al. Polyautoimmunity and familial autoimmunity in systemic sclerosis. J Autoimmun 31 (2008) 156-159
3. Scutera S., Fraone T., Musso T., Cappello P., Rossi S., Pierobon D., et al. Survival and migration of human dendritic cells are regulated by an ifn-alpha-inducible axl/gas6 pathway. J Immunol 183 (2009) 3004-3013
4. Luther C., Adamopoulou E., Stoeckle C., Brucklacher-Waldert V., Rosenkranz D., Stoltze L., et al. Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients. J Immunol 183 (2009) 841-848
5. Platzer B., Richter S., Kneidinger D., Waltenberger D., Woisetschlager M., and Strobl H. Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and langerhans dendritic cells. J Immunol 183 (2009) 66-74
6. Sa-Nunes A., Bafica A., Antonelli L.R., Choi E.Y., Francischetti I.M., Andersen J.F., et al. The immunomodulatory action of sialostatin l on dendritic cells reveals its potential to interfere with autoimmunity. J Immunol 182 (2009) 7422-7429
7. Smith T.R., Tang X., Maricic I., Garcia Z., Fanchiang S., and Kumar V. Dendritic cells use endocytic pathway for cross-priming class ib mhc-restricted cd8alphaalpha + tcralphabeta + t cells with regulatory properties. J Immunol 182 (2009) 6959-6968
8. Doisne J.M., Becourt C., Amniai L., Duarte N., Le Luduec J.B., Eberl G., et al. Skin and peripheral lymph node invariant nkt cells are mainly retinoic acid receptor-related orphan receptor (gamma)t+ and respond preferentially under inflammatory conditions. J Immunol 183 (2009) 2142-2149
9. Burt B.M., Plitas G., Zhao Z., Bamboat Z.M., Nguyen H.M., Dupont B., et al. The lytic potential of human liver nk cells is restricted by their limited expression of inhibitory killer ig-like receptors. J Immunol 183 (2009) 1789-1796
10. Green N.M., Laws A., Kiefer K., Busconi L., Kim Y.M., Brinkmann M.M., et al. Murine b cell response to tlr7 ligands depends on an ifn-beta feedback loop. J Immunol 183 (2009) 1569-1576
11. van der Putten C., Zuiderwijk-Sick E.A., van Straalen L., de Geus E.D., Boven L.A., Kondova I., et al. Differential expression of adenosine a3 receptors controls adenosine a2a receptor-mediated inhibition of tlr responses in microglia. J Immunol 182 (2009) 7603-7612
12. Joncker N.T., Fernandez N.C., Treiner E., Vivier E., and Raulet D.H. Nk cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-mhc class i: the rheostat model. J Immunol 182 (2009) 4572-4580
13. Henry C.J., Ornelles D.A., Mitchell L.M., Brzoza-Lewis K.L., and Hiltbold E.M. Il-12 produced by dendritic cells augments cd8+ t cell activation through the production of the chemokines ccl1 and ccl17. J Immunol 181 (2008) 8576-8584
14. Zigmond E., Shalev Z., Pappo O., Alper R., Zolotarov L., and Ilan Y. Nkt lymphocyte polarization determined by microenvironment signaling: a role for cd8+ lymphocytes and beta-glycosphingolipids. J Autoimmun 31 (2008) 188-195
15. Vidalino L., Doria A., Quarta S., Zen M., Gatta A., and Pontisso P. Serpinb3, apoptosis and autoimmunity. Autoimmun Rev 9 (2009) 108-112
16. Sansonno L., Tucci F.A., Sansonno S., Lauletta G., Troiani L., and Sansonno D. B cells and hcv: an infection model of autoimmunity. Autoimmun Rev 9 (2009) 93-94
17. Toth B., Garabuczi E., Sarang Z., Vereb G., Vamosi G., Aeschlimann D., et al. Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells. J Immunol 182 (2009) 2084-2092
18. Ramos S.J., Hernandez J.B., Gatzka M., and Walsh C.M. Enhanced t cell apoptosis within drak2-deficient mice promotes resistance to autoimmunity. J Immunol 181 (2008) 7606-7616
19. Lleo A., Selmi C., Invernizzi P., Podda M., and Gershwin M.E. The consequences of apoptosis in autoimmunity. J Autoimmun 31 (2008) 257-262
20. Crotzer V.L., and Blum J.S. Autophagy and its role in mhc-mediated antigen presentation. J Immunol 182 (2009) 3335-3341
21. Mackay I.R., Leskovsek N.V., and Rose N.R. Cell damage and autoimmunity: a critical appraisal. J Autoimmun 30 (2008) 5-11
22. Mathieu A., Paladini F., Vacca A., Cauli A., Fiorillo M.T., and Sorrentino R. The interplay between the geographic distribution of hla-b27 alleles and their role in infectious and autoimmune diseases: a unifying hypothesis. Autoimmun Rev 8 (2009) 420-425
23. Invernizzi P. Future directions in genetic for autoimmune diseases. J Autoimmun 33 (2009) 1-2
24. Invernizzi P., and Gershwin M.E. The genetics of human autoimmune disease. J Autoimmun 33 (2009) 290-299
25. Lempainen J., Vaarala O., Makela M., Veijola R., Simell O., Knip M., et al. Interplay between ptpn22 c1858t polymorphism and cow's milk formula exposure in type 1 diabetes. J Autoimmun 33 (2009) 155-164
26. Hewagama A., and Richardson B. The genetics and epigenetics of autoimmune diseases. J Autoimmun 33 (2009) 3-11
27. Tomer Y., and Huber A. The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun 32 (2009) 231-239
28. Sim D.L., Bagavant H., Scindia Y.M., Ge Y., Gaskin F., Fu S.M., et al. Genetic complementation results in augmented autoantibody responses to lupus-associated antigens. J Immunol 183 (2009) 3505-3511
29. de Kauwe A.L., Chen Z., Anderson R.P., Keech C.L., Price J.D., Wijburg O., et al. Resistance to celiac disease in humanized hla-dr3-dq2-transgenic mice expressing specific anti-gliadin cd4+ t cells. J Immunol 182 (2009) 7440-7450
30. Muixi L., Carrascal M., Alvarez I., Daura X., Marti M., Armengol M.P., et al. Thyroglobulin peptides associate in vivo to hla-dr in autoimmune thyroid glands. J Immunol 181 (2008) 795-807
31. Baschal E.E., and Eisenbarth G.S. Extreme genetic risk for type 1a diabetes in the post-genome era. J Autoimmun 31 (2008) 1-6
32. Etzensperger R., McMahon R.M., Jones E.Y., and Fugger L. Dissection of the multiple sclerosis associated dr2 haplotype. J Autoimmun 31 (2008) 201-207
33. Buxbaum J., Qian P., Allen P.M., and Peters M.G. Hepatitis resulting from liver-specific expression and recognition of self-antigen. J Autoimmun 31 (2008) 208-215
34. Culton D.A., Qian Y., Li N., Rubenstein D., Aoki V., Filhio G.H., et al. Advances in pemphigus and its endemic pemphigus foliaceus (fogo selvagem) phenotype: a paradigm of human autoimmunity. J Autoimmun 31 (2008) 311-324
35. Praprotnik S., Sodin-Semrl S., Tomsic M., and Shoenfeld Y. The curiously suspicious: infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients. J Autoimmun 30 (2008) 37-41
36. Aota N., and Shiohara T. Viral connection between drug rashes and autoimmune diseases: how autoimmune responses are generated after resolution of drug rashes. Autoimmun Rev 8 (2009) 488-494
37. Poole B.D., Templeton A.K., Guthridge J.M., Brown E.J., Harley J.B., and James J.A. Aberrant epstein-barr viral infection in systemic lupus erythematosus. Autoimmun Rev 8 (2009) 337-342
38. Teijaro J.R., Njau M.N., Verhoeven D., Chandran S., Nadler S.G., Hasday J., et al. Costimulation modulation uncouples protection from immunopathology in memory t cell responses to influenza virus. J Immunol 182 (2009) 6834-6843
39. Pierer M., Schulz A., Rossol M., Kendzia E., Kyburz D., Haentzschel H., et al. Herpesvirus entry mediator-ig treatment during immunization aggravates rheumatoid arthritis in the collagen-induced arthritis model. J Immunol 182 (2009) 3139-3145
40. Fairweather D., and Cihakova D. Alternatively activated macrophages in infection and autoimmunity. J Autoimmun 33 (2009) 222-230
41. Frazer I.H. Autoimmunity and persistent viral infection: two sides of the same coin?. J Autoimmun 31 (2008) 216-218
42. Shi J., Sun X., Zhao Y., Zhao J., and Li Z. Prevalence and significance of antibodies to citrullinated human papilloma virus-47 e2(345-362) in rheumatoid arthritis. J Autoimmun 31 (2008) 131-135
43. Sawalha A.H., Harley J.B., and Scofield R.H. Autoimmunity and klinefelter's syndrome: when men have two x chromosomes. J Autoimmun 33 (2009) 31-34
44. Pessach I.M., and Notarangelo L.D. X-linked primary immunodeficiencies as a bridge to better understanding x-chromosome related autoimmunity. J Autoimmun 33 (2009) 17-24
45. Invernizzi P., Pasini S., Selmi C., Gershwin M.E., and Podda M. Female predominance and x chromosome defects in autoimmune diseases. J Autoimmun 33 (2009) 12-16
46. Larizza D., Calcaterra V., and Martinetti M. Autoimmune stigmata in Turner syndrome: when lacks an x chromosome. J Autoimmun 33 (2009) 25-30
47. Persani L., Rossetti R., Cacciatore C., and Bonomi M. Primary ovarian insufficiency: x chromosome defects and autoimmunity. J Autoimmun 33 (2009) 35-41
48. Santiago-Raber M.L., Kikuchi S., Borel P., Uematsu S., Akira S., Kotzin B.L., et al. Evidence for genes in addition to tlr7 in the yaa translocation linked with acceleration of systemic lupus erythematosus. J Immunol 181 (2008) 1556-1562
49. Padgett K.A., Lan R.Y., Leung P.C., Lleo A., Dawson K., Pfeiff J., et al. Primary biliary cirrhosis is associated with altered hepatic microrna expression. J Autoimmun 32 (2009) 246-253
50. Pauley K.M., Cha S., and Chan E.K. Microrna in autoimmunity and autoimmune diseases. J Autoimmun 32 (2009) 189-194
51. Bautista J.L., Lio C.W., Lathrop S.K., Forbush K., Liang Y., Luo J., et al. Intraclonal competition limits the fate determination of regulatory t cells in the thymus. Nat Immunol 10 (2009) 610-617
52. Askenasy N., Kaminitz A., and Yarkoni S. Mechanisms of t regulatory cell function. Autoimmun Rev 7 (2008) 370-375
53. Lee H.M., and Hsieh C.S. Rare development of foxp3+ thymocytes in the cd4+ cd8+ subset. J Immunol 183 (2009) 2261-2266
54. Jordan M.A., and Baxter A.G. The genetics of immunoregulatory t cells. J Autoimmun 31 (2008) 237-244
55. Iikuni N., Lourenco E.V., Hahn B.H., and La Cava A. Cutting edge: regulatory t cells directly suppress b cells in systemic lupus erythematosus. J Immunol 183 (2009) 1518-1522
56. O'Gorman W.E., Dooms H., Thorne S.H., Kuswanto W.F., Simonds E.F., Krutzik P.O., et al. The initial phase of an immune response functions to activate regulatory t cells. J Immunol 183 (2009) 332-339
57. Takahashi N., Matsumoto K., Saito H., Nanki T., Miyasaka N., Kobata T., et al. Impaired cd4 and cd8 effector function and decreased memory t cell populations in icos-deficient patients. J Immunol 182 (2009) 5515-5527
58. Molinero L.L., Yang J., Gajewski T., Abraham C., Farrar M.A., and Alegre M.L. Carma1 controls an early checkpoint in the thymic development of foxp3+ regulatory t cells. J Immunol 182 (2009) 6736-6743
59. Jacob J.B., Kong Y.C., Nalbantoglu I., Snower D.P., and Wei W.Z. Tumor regression following DNA vaccination and regulatory t cell depletion in neu transgenic mice leads to an increased risk for autoimmunity. J Immunol 182 (2009) 5873-5881
60. Vogtenhuber C., O'Shaughnessy M.J., Vignali D.A., and Blazar B.R. Outgrowth of cd4low/negcd25+ t cells with suppressor function in cd4+ cd25+ t cell cultures upon polyclonal stimulation ex vivo. J Immunol 181 (2008) 8767-8775
61. Sgouroudis E., Albanese A., and Piccirillo C.A. Impact of protective il-2 allelic variants on cd4+ foxp3+ regulatory t cell function in situ and resistance to autoimmune diabetes in nod mice. J Immunol 181 (2008) 6283-6292
62. Radhakrishnan S., Cabrera R., Schenk E.L., Nava-Parada P., Bell M.P., Van Keulen V.P., et al. Reprogrammed foxp3+ t regulatory cells become il-17+ antigen-specific autoimmune effectors in vitro and in vivo. J Immunol 181 (2008) 3137-3147
63. Winstead C.J., Fraser J.M., and Khoruts A. Regulatory cd4 + cd25 + foxp3+ t cells selectively inhibit the spontaneous form of lymphopenia-induced proliferation of naive t cells. J Immunol 180 (2008) 7305-7317
64. Chen G.Y., Chen C., Wang L., Chang X., Zheng P., and Liu Y. Cutting edge: broad expression of the foxp3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of foxp3-expressing cells. J Immunol 180 (2008) 5163-5166
65. Terme M., Chaput N., Combadiere B., Ma A., Ohteki T., and Zitvogel L. Regulatory t cells control dendritic cell/nk cell cross-talk in lymph nodes at the steady state by inhibiting cd4+ self-reactive t cells. J Immunol 180 (2008) 4679-4686
66. McGeachy M.J., Chen Y., Tato C.M., Laurence A., Joyce-Shaikh B., Blumenschein W.M., et al. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector t helper cells in vivo. Nat Immunol 10 (2009) 314-324
67. Volpe E., Servant N., Zollinger R., Bogiatzi S.I., Hupe P., Barillot E., et al. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human t(h)-17 responses. Nat Immunol 9 (2008) 650-657
68. Hsu H.C., Yang P., Wang J., Wu Q., Myers R., Chen J., et al. Interleukin 17-producing t helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune bxd2 mice. Nat Immunol 9 (2008) 166-175
69. Murugaiyan G., Mittal A., Lopez-Diego R., Maier L.M., Anderson D.E., and Weiner H.L. Il-27 is a key regulator of il-10 and il-17 production by human cd4+ t cells. J Immunol 183 (2009) 2435-2443
70. Walsh K.P., Brady M.T., Finlay C.M., Boon L., and Mills K.H. Infection with a helminth parasite attenuates autoimmunity through tgf-beta-mediated suppression of th17 and th1 responses. J Immunol 183 (2009) 1577-1586
71. Locke N.R., Patterson S.J., Hamilton M.J., Sly L.M., Krystal G., and Levings M.K. Ship regulates the reciprocal development of t regulatory and th17 cells. J Immunol 183 (2009) 975-983
72. Xu J., Yang Y., Qiu G., Lal G., Wu Z., Levy D.E., et al. C-maf regulates il-10 expression during th17 polarization. J Immunol 182 (2009) 6226-6236
73. Tang J., Zhou R., Luger D., Zhu W., Silver P.B., Grajewski R.S., et al. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the th17 effector response. J Immunol 182 (2009) 4624-4632
74. Jaffar Z., Ferrini M.E., Herritt L.A., and Roberts K. Cutting edge: lung mucosal th17-mediated responses induce polymeric ig receptor expression by the airway epithelium and elevate secretory iga levels. J Immunol 182 (2009) 4507-4511
75. Skarica M., Wang T., McCadden E., Kardian D., Calabresi P.A., Small D., et al. Signal transduction inhibition of apcs diminishes th17 and th1 responses in experimental autoimmune encephalomyelitis. J Immunol 182 (2009) 4192-4199
76. Gonzalez-Garcia I., Zhao Y., Ju S., Gu Q., Liu L., Kolls J.K., et al. Il-17 signaling-independent central nervous system autoimmunity is negatively regulated by tgf-beta. J Immunol 182 (2009) 2665-2671
77. Chauhan S.K., El Annan J., Ecoiffier T., Goyal S., Zhang Q., Saban D.R., et al. Autoimmunity in dry eye is due to resistance of th17 to treg suppression. J Immunol 182 (2009) 1247-1252
78. Yang Y., Xu J., Niu Y., Bromberg J.S., and Ding Y. T-bet and eomesodermin play critical roles in directing t cell differentiation to th1 versus th17. J Immunol 181 (2008) 8700-8710
79. Nagata T., McKinley L., Peschon J.J., Alcorn J.F., Aujla S.J., and Kolls J.K. Requirement of il-17ra in con a induced hepatitis and negative regulation of il-17 production in mouse t cells. J Immunol 181 (2008) 7473-7479
80. Grajewski R.S., Hansen A.M., Agarwal R.K., Kronenberg M., Sidobre S., Su S.B., et al. Activation of invariant nkt cells ameliorates experimental ocular autoimmunity by a mechanism involving innate ifn-gamma production and dampening of the adaptive th1 and th17 responses. J Immunol 181 (2008) 4791-4797
81. Dardalhon V., Korn T., Kuchroo V.K., and Anderson A.C. Role of th1 and th17 cells in organ-specific autoimmunity. J Autoimmun 31 (2008) 252-256
82. Hubert F.X., Kinkel S.A., Crewther P.E., Cannon P.Z., Webster K.E., Link M., et al. Aire-deficient c57bl/6 mice mimicking the common human 13-base pair deletion mutation present with only a mild autoimmune phenotype. J Immunol 182 (2009) 3902-3918
83. Fletcher A.L., Seach N., Reiseger J.J., Lowen T.E., Hammett M.V., Scott H.S., et al. Reduced thymic aire expression and abnormal nf-kappa b2 signaling in a model of systemic autoimmunity. J Immunol 182 (2009) 2690-2699
84. Allina J., Stanca C.M., Garber J., Hu B., Sautes-Fridman C., Bach N., et al. Anti-cd16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis. J Autoimmun 30 (2008) 238-245
85. Boscolo P., Youinou P., Theoharides T.C., Cerulli G., and Conti P. Environmental and occupational stress and autoimmunity. Autoimmun Rev 7 (2008) 340-343
86. Dalloul A. Cd5: a safeguard against autoimmunity and a shield for cancer cells. Autoimmun Rev 8 (2008) 349-353
87. Dimitrov J.D., Vassilev T.L., Andre S., Kaveri S.V., and Lacroix-Desmazes S. Functional variability of antibodies upon oxidative processes. Autoimmun Rev 7 (2008) 574-578
88. Elluru S.R., Vani J., Delignat S., Bloch M.F., Lacroix-Desmazes S., Kazatchkine M.D., et al. Modulation of human dendritic cell maturation and function by natural igg antibodies. Autoimmun Rev 7 (2008) 487-490
89. Fiocco U., Sfriso P., Oliviero F., Pagnin E., Scagliori E., Campana C., et al. Co-stimulatory modulation in rheumatoid arthritis: the role of (ctla4-ig) abatacept. Autoimmun Rev 8 (2008) 76-82
90. Gebe J.A., Unrath K.A., Yue B.B., Miyake T., Falk B.A., and Nepom G.T. Autoreactive human t-cell receptor initiates insulitis and impaired glucose tolerance in hla dr4 transgenic mice. J Autoimmun 30 (2008) 197-206
91. Gonnella P.A., Waldner H., Del Nido P.J., and McGowan F.X. Inhibition of experimental autoimmune myocarditis: peripheral deletion of tcr vbeta 8.1, 8.2+ cd4+ t cells in tlr-4 deficient mice. J Autoimmun 31 (2008) 180-187
92. Katzav A., Ben-Ziv T., Chapman J., Blank M., Reichlin M., and Shoenfeld Y. Anti-p ribosomal antibodies induce defect in smell capability in a model of cns-sle (depression). J Autoimmun 31 (2008) 393-398
93. Lorusso L., Mikhaylova S.V., Capelli E., Ferrari D., Ngonga G.K., and Ricevuti G. Immunological aspects of chronic fatigue syndrome. Autoimmun Rev 8 (2009) 287-291
94. Neuhausen S.L., Steele L., Ryan S., Mousavi M., Pinto M., Osann K.E., et al. Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives. J Autoimmun 31 (2008) 160-165
95. Marmont A.M. Will hematopoietic stem cell transplantation cure human autoimmune diseases?. J Autoimmun 30 (2008) 145-150
96. Stojanovich L., and Marisavljevich D. Stress as a trigger of autoimmune disease. Autoimmun Rev 7 (2008) 209-213
97. Takaki T., Hosaka N., Miyake T., Cui W., Nishida T., Inaba M., et al. Presence of donor-derived thymic epithelial cells in [b6->mrl/lpr] mice after allogeneic intra-bone marrow-bone marrow transplantation (ibm-bmt). J Autoimmun 31 (2008) 408-415
98. Burt R.K., Testori A., Craig R., Cohen B., Suffit R., and Barr W. Hematopoietic stem cell transplantation for autoimmune diseases: what have we learned?. J Autoimmun 30 (2008) 116-120
99. Deane S., Meyers F.J., and Gershwin M.E. On reversing the persistence of memory: hematopoietic stem cell transplant for autoimmune disease in the first ten years. J Autoimmun 30 (2008) 180-196
100. Ingegnoli F., Fantini F., Favalli E.G., Soldi A., Griffini S., Galbiati V., et al. Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade. J Autoimmun 31 (2008) 175-179